Abstract Information




Late-Breaking Discoveries Abstracts Submission Opens:



December 9, 2016

Submission Deadline:

January 9, 2017 
(23:59 U.S. US Eastern)


No later than January 19, 2017

Withdrawal Deadline:

January 31, 2017

All participants at the AMP Global 2017 Congress on Molecular Pathology are invited to submit abstracts of original studies related to molecular pathology and diagnostics.


QUICK LINKS / Resources

Eligibility, Categories, Deadlines

Submission Checklist

Abstract Format Requirements

Submission Guide

Author Information

Style Guide

Submit Now!



Eligibility: All participants who are interested in molecular diagnostics are invited to submit abstracts in English of original studies related to molecular pathology and diagnostics, including lab professionals, clinicians, pathologists, technologists, and doctoral trainees. For the inaugural AMP Global Congress, there is no sponsorship by an AMP Member or AMP Membership required to submit an abstract, but AMP members DO receive discounted meeting registration rate! Interested in learning more about all the benefits of AMP Membership? Visit www.ampberlin2017.com/Join


Submission Categories:

  • Genetics
  • Hematopathology
  • Infectious Diseases
  • Informatics
  • Solid Tumors
  • Technical Topics
  • Other (Education, etc.)*


*Abstract submissions in the "Other (Education, etc.)" topic category may include descriptions of novel educational approaches, innovative programs, pioneering technologies, etc. As with other abstract submissions, these abstract submissions must demonstrate the scientific method, i.e., describe the methodology and data collection, identify how to measure, analyze, and report outcomes, and provide conclusions. All submitted abstracts will be reviewed with the same criteria (see below).


Deadline: Complete abstracts must be submitted online in English no later than 13:00 U.S. US Eastern/19:00 Central European Time Zone on Wednesday, November 30, 2016. All abstract submissions must be complete and finalized before this time and date - NO EXCEPTIONS. The final abstract submission step is not complete until you have clicked the "Finalize and Save" button. Only the Corresponding Author will receive an automatically-generated confirmation email only after your abstract has been successfully finalized and submitted. Abstracts that are in process but not finalized after the deadline will not be considered for acceptance and/or awards.


Notification: The Corresponding Author will be notified by email no later than mid-January, 2017. Accepted abstracts will be published as an online supplement to the March 2017 issue of The Journal of Molecular Diagnostics (JMD) (see "Eligibility for Publication" section). Abstracts that are not eligible for publication in JMD, i.e., have been submitted to another publication or to another meeting that occurs prior to April 2017, will be rejected. Abstracts may be withdrawn until Tuesday, January 31, 2017.


Embargo: The research presented as posters at the AMP Global Congress from the abstracts published as an online supplement to the March issue of JMD is embargoed until the first day of poster presentations at the Global Congress.


Poster Presentations: First authors of accepted abstracts are expected to register as an attendee and present posters at the Global Congress summarizing their studies. Submitting an abstract for poster presentation does not constitute registration for the AMP Global Congress. All authors of abstracts must adhere to the AMP Scientific Integrity Policy.


Platform Presentations: Several abstracts will be selected by the Organizing Committee to be presented as an oral Platform Presentation (on Tuesday, April 4) in addition to a Poster.






Abstracts that are not submitted properly will receive an administrative reject and will not be reviewed.

  1. Abstracts must be submitted properly and in English. The online system is a database, with data fields (title, author 1, author 2, author 3, etc.) that are used to generate the published abstracts. Therefore, pay careful attention to the submission instructions and to the submission process, including spelling, capitalization, author names, etc.
  2. All abstracts must include the required headers listed below; each header must be included in your text:
    • Introduction: a brief discussion of the background or rationale of the study and/or the question addressed
    • Methods: the experimental approach, materials, and methods used in the study
    • Results: the data and results obtained in the study
    • Conclusions: the conclusions and/or implications of the results
  3. Abstract Limits:
    • Number of authors: 30
    • Abstract Title: 200 characters
    • Abstract Content: 2800 characters (with spaces and including section headers)
  4. You may include formatting (italicizing genes), Greek letters and special symbols, e.g., °C (degree sign), supersripts, etc. Data must be reported in narrative format in the abstract submission; tables may be included in your poster.
  5. Your abstract will be rated using four criteria:
    • Originality and Clarity
    • Novelty
    • Scientific Merit/Rigor
    • Appropriate Conclusions
  6. Summary: Grounds for abstract rejection are:
    • Failure to follow directions in 1-4.
    • Abstracts that are not eligible for publication in JMD, i.e., have been submitted to another publication or to another meeting that occurs prior to April 2017.
    • Abstract contains no scientific data or has only a promise of future data.
    • Duplicate abstracts are submitted.
    • Any author violated any of the AMP rules for presentation at a previous meeting, e.g., the authors failed to present a poster without notifying AMP prior to the meeting.


The five most common reasons for rejection are:

  • Previously presented/published
  • Poor organization/clarity
  • Does not provide novel information
  • Insufficient scientific quality
  • Insufficient data




  1. The Corresponding (Submitting) Author is the individual who submits the abstract and is the contact person for all correspondence from AMP. The Corresponding Author does not need to be the senior author. The Corresponding Author has the following responsibilities:
    • verifies that all authors agree to the publication of the abstract in JMD.
    • verifies that all authors agree, and any supervisors have given permission, to the presentation of a scientific poster at the annual meeting.
    • responsible for notifying all other authors of acceptance, rejection, scheduling and any other information provided by AMP.
    • responsible for notifying the Presenting (First) Author of the AMP Rules for Poster Display and any other information provided by AMP. Young Investigator Award applicants are responsible for notifying their faculty mentors of the additional rules for poster display for award (see "AWARDS INFORMATION" section).
    • responsible for compliance with the AMP Scientific Integrity Policy.
  2. The First Author is also considered the Presenting Author (who may be the Corresponding Author) and has the following responsibilities:
    • expected to register for the Global Congress and attend the poster at the assigned time period to discuss the study and answer questions. If the Presenting Author is unable to attend the Global Congress to present the poster, every effort should be made to arrange for one of the other authors to present the poster. Both AMP ([email protected]) and the Global Congress Organizing Committee Chair, Dr. Margaret Gulley ([email protected]), must be notified. Failure to defend one's study by not attending the poster during the assigned time period is a violation of the AMP Scientific Integrity Policy and may result in forfeiture of future abstract submission privileges.
    • expected to ensure that the abstract poster conforms to the Rules for Poster Display at the Global Congress (i.e., poster display size, format, and schedule).
  3. Please note that accepted abstracts that have not been previously published as either an abstract or a paper will be eligible for publication as an online supplement to the March 2017 issue of JMD. Abstracts that have been previously published or that are under consideration as an abstract for another meeting that occurs prior to April 2017 will be rejected.